Matthias Aizenberg

The global market for in-vitro inflammatory bowel disease diagnostics is projected to climb to USD 2.9 billion by 2034 as healthcare providers shift toward non-invasive protocols. This movement reflects a broader transformation within the gastrointestinal sector, where the focus is intensifying on

Surgeons can better predict the risk of failed back surgery syndrome by using automated metrics to evaluate a patient's physical condition before they enter the operating room. This technological shift addresses a longstanding gap in spinal diagnostics where clinicians traditionally focused on

The Strap Pro distinguishes itself from competitors like WHOOP by offering full access to health and recovery data without a mandatory monthly subscription. This strategic pivot arrives at a time when the consumer electronics industry has become increasingly reliant on recurring revenue models,

Metabolic dysfunction-associated steatohepatitis represents a severe condition where active fibrosis acts as the primary predictor of liver-related mortality rates. This silent progression of connective tissue buildup, known as fibrosis, has long plagued the medical community because it remains

The success of [¹⁸F] AlF-NOTA-Pentixafor in detecting shallow and diffuse gastric tumors represents a pivotal step in refining oncology protocols for indolent lymphomas. Gastric mucosa-associated lymphoid tissue (MALT) lymphoma has long remained one of the most elusive targets in clinical oncology

A study presented at the European Emergency Medicine Congress reveals that early stabilization of blood pressure is more effective when patients are shielded from the environmental stressors of the hospital. In the high-pressure environment of the emergency department, clinicians are constantly

By anchoring molecular heat maps within real-time ultrasound guidance, clinicians can significantly reduce the risk of under-diagnosing aggressive prostate disease. For decades, the medical community has grappled with the inherent limitations of diagnosing clinically significant prostate cancer

While the MyChart portal is once again accessible for scheduling and messaging, patients may find a significant data gap regarding lab results and physician notes generated during the September outage. This announcement from Luminis Health on September 29 marks the cautious conclusion of a digital

Pharmacists are utilizing weight management scales and blood pressure monitors to bridge the diagnostic gap between physical consultations. This shift marks a transition from the traditional role of medication dispensing to a comprehensive clinical-first approach within independent pharmacies. By

Moving diagnostic capabilities from the doctor’s office into the patient’s home addresses the inherent limitations of intermittent clinical visits and late-stage diagnoses. This transition is particularly critical for managing conditions like atrial fibrillation, or A-Fib, which often operates as a